Indian J Pharm Close
 

Figure 3: Neurological function of Carthamus tinctorius L. on cerebral ischemia in rats. (A) Infarction behavior of rats; (B) Hematoxylin and eosin staining for brain tissues of cerebral ischemic rats, a. Normal, b. Sham, c. Model, d. positive drug Nimodipine group (7.53 mg/kg/d), e. high dose Carthamus tinctorius L. group (4 g crude drug/kg/d), f. low dose Carthamus tinctorius L. group (2 g crude drug/kg/d); (C) Neurological deficit scores of cerebral ischemic rats on the 1st day, 7th day, and 14th day; Magnification × 200. Data are presented as means ± standard deviation (n = 8). *P < 0.05, **P < 0.01, 7th day or 14th day versus 1st day

Figure 3: Neurological function of <i>Carthamus tinctorius</i> L. on cerebral ischemia in rats. (A) Infarction behavior of rats; (B) Hematoxylin and eosin staining for brain tissues of cerebral ischemic rats, a. Normal, b. Sham, c. Model, d. positive drug Nimodipine group (7.53 mg/kg/d), e. high dose <i>Carthamus tinctorius</i> L. group (4 g crude drug/kg/d), f. low dose <i>Carthamus tinctorius</i> L. group (2 g crude drug/kg/d); (C) Neurological deficit scores of cerebral ischemic rats on the 1<sup>st</sup> day, 7<sup>th</sup> day, and 14<sup>th</sup> day; Magnification × 200. Data are presented as means ± standard deviation (<i>n</i> = 8). *<i>P</i> < 0.05, **<i>P</i> < 0.01, 7<sup>th</sup> day or 14<sup>th</sup> day versus 1<sup>st</sup> day